Life-saving compound developed and patented at UToledo licensed to Prolong Pharmaceuticals

A compound developed at The University of Toledo that can be used to prevent blood vessels from leaking fluid into surrounding tissue following a traumatic injury to the human body has been licensed to Prolong Pharmaceuticals for...

Prolong Pharmaceuticals Presents Phase 1 Results For Flagship Product SANGUINATE™

SOUTH PLAINFIELD, N.J., Oct. 3, 2013 /PRNewswire/ -- Prolong Pharmaceuticals LLC, a biopharmaceutical company developing products to treat several diseases and their debilitating comorbidities presented Phase I results of its lead product, SANGUINATE™ at the...